The ideal interval for breast cancer screening depends on combined assessments of each woman’s breast cancer risk and her breast density, according to a new study led by UC San Francisco and University of Wisconsin (UW) researchers. The research team, members of two nationwide breast ...

Karla Kerlikowske, MD, a co-principal investigator of the Breast Cancer Surveillance Consortium(BCSC), is part of the team awarded $7.5 million by the Patient-Centered Outcomes Research Institute(PCORI) board of governors to determine the effectiveness of two supplemental breast screening and diagnostic workup strategies.

Cancer specialists from UC San Francisco will share information on advances in research during the annual meeting of the American Society of Clinical Oncology (ASCO), one of the world’s most prestigious gatherings of oncology professionals.

Time magazine has named internationally renowned breast cancer oncologist Laura Esserman, MD, MBA, to the2016 TIME 100, the magazine’s annual list of the 100 most influential people in the world.

As more people get their hands on their own genetic data each day, many face an increasingly common question: What do you do if you carry a genetic risk factor for cancer?

The most intractable common form of breast cancer might in most cases be treatable by drugs that target fat metabolism, according to UC San Francisco researchers who discovered the tumors’ frequent dependence on fat as an energy source, and then successfully treated human breast tumors that they transplanted and grew in mice.